| Year |
Citation |
Score |
| 2023 |
Kalaba P, Pacher K, Neill PJ, Dragacevic V, Zehl M, Wackerlig J, Kirchhofer M, Sartori SB, Gstach H, Kouhnavardi S, Fabisikova A, Pillwein M, Monje-Quiroga F, Ebner K, Prado-Roller A, ... ... Pifl C, et al. Chirality Matters: Fine-Tuning of Novel Monoamine Reuptake Inhibitors Selectivity through Manipulation of Stereochemistry. Biomolecules. 13. PMID 37759815 DOI: 10.3390/biom13091415 |
0.306 |
|
| 2023 |
Pifl C, Reither H, Attems J, Zecca L. Dopamine and vesicular monoamine transport loss supports incidental Lewy body disease as preclinical idiopathic Parkinson. Npj Parkinson's Disease. 9: 89. PMID 37322038 DOI: 10.1038/s41531-023-00514-z |
0.513 |
|
| 2023 |
Cronin SJF, Yu W, Hale A, Licht-Mayer S, Crabtree MJ, Korecka JA, Tretiakov EO, Sealey-Cardona M, Somlyay M, Onji M, An M, Fox JD, Turnes BL, Gomez-Diaz C, da Luz Scheffer D, ... ... Pifl C, et al. Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons. Biorxiv : the Preprint Server For Biology. PMID 37214873 DOI: 10.1101/2023.05.08.539795 |
0.31 |
|
| 2021 |
da Silva SR, Kalaba P, Fabišiková A, Zehl M, Dragačević V, Dos Anjos LR, Neill PJ, Wieder M, Prado-Roller A, Gajic N, Palaretti V, da Silva GVJ, Pifl C, Lubec G, Gonzalez ERP. Synthesis and dopamine receptor binding of dihydrexidine and SKF 38393 catecholamine-based analogues. Amino Acids. PMID 34842969 DOI: 10.1007/s00726-021-03106-4 |
0.415 |
|
| 2021 |
Lubec J, Kalaba P, Hussein AM, Feyissa DD, Kotob MH, Mahmmoud RR, Wieder O, Garon A, Sagheddu C, Ilic M, Dragačević V, Cybulska-Klosowicz A, Zehl M, Wackerlig J, Sartori SB, ... ... Pifl C, et al. Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition. Molecular Psychiatry. PMID 34244620 DOI: 10.1038/s41380-021-01214-x |
0.386 |
|
| 2020 |
Rotolo RA, Kalaba P, Dragacevic V, Presby RE, Neri J, Robertson E, Yang JH, Correa M, Bakulev V, Volkova NN, Pifl C, Lubec G, Salamone JD. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. Psychopharmacology. PMID 32770257 DOI: 10.1007/S00213-020-05625-6 |
0.485 |
|
| 2020 |
Pifl C, Sitte HH. A Tribute to Oleh Hornykiewicz (1926–2020) Trends in Pharmacological Sciences. 41: 499-501. DOI: 10.1016/J.Tips.2020.06.004 |
0.51 |
|
| 2019 |
Kalaba P, Ilić M, Aher NY, Dragačević V, Wieder M, Zehl M, Wackerlig J, Beyl S, Sartori SB, Ebner K, Roller A, Lukic N, Beryozkina TV, González ERP, Neill PJ, ... ... Pifl C, et al. Structure Activity Relationships of Novel Thiazole-Based Modafinil Analogues Acting at Monoamine Transporters. Journal of Medicinal Chemistry. PMID 31841637 DOI: 10.1021/Acs.Jmedchem.9B01938 |
0.394 |
|
| 2019 |
Korchynska S, Krassnitzer M, Malenczyk K, Prasad RB, Tretiakov EO, Rehman S, Cinquina V, Gernedl V, Farlik M, Petersen J, Hannes S, Schachenhofer J, Reisinger SN, Zambon A, Asplund O, ... ... Pifl C, et al. Life-long impairment of glucose homeostasis upon prenatal exposure to psychostimulants. The Embo Journal. e100882. PMID 31750562 DOI: 10.15252/Embj.2018100882 |
0.325 |
|
| 2019 |
Hörtnagl H, Pifl C, Hörtnagl E, Reiner A, Sperk G. Distinct gradients of various neurotransmitter markers in caudate nucleus and putamen of the human brain. Journal of Neurochemistry. PMID 31608979 DOI: 10.1111/Jnc.14897 |
0.528 |
|
| 2019 |
Dorninger F, König T, Scholze P, Berger ML, Zeitler G, Wiesinger C, Gundacker A, Pollak DD, Huck S, Just WW, Forss-Petter S, Pifl C, Berger J. Disturbed Neurotransmitter Homeostasis in Ether Lipid Deficiency. Human Molecular Genetics. PMID 30759250 DOI: 10.1093/Hmg/Ddz040 |
0.346 |
|
| 2018 |
Alpár A, Zahola P, Hanics J, Hevesi Z, Korchynska S, Benevento M, Pifl C, Zachar G, Perugini J, Severi I, Leitgeb P, Bakker J, Miklosi AG, Tretiakov E, Keimpema E, et al. Hypothalamic CNTF volume transmission shapes cortical noradrenergic excitability upon acute stress. The Embo Journal. PMID 30209240 DOI: 10.15252/Embj.2018100087 |
0.328 |
|
| 2018 |
Maier J, Mayer FP, Luethi D, Holy M, Jäntsch K, Reither H, Hirtler L, Hoener MC, Liechti ME, Pifl C, Brandt SD, Sitte HH. The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters. Neuropharmacology. PMID 29908239 DOI: 10.1016/J.Neuropharm.2018.06.018 |
0.456 |
|
| 2017 |
Pifl C, Reither H, Del Rey NL, Cavada C, Obeso JA, Blesa J. Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys. Frontiers in Neuroanatomy. 11: 46. PMID 28611598 DOI: 10.3389/Fnana.2017.00046 |
0.531 |
|
| 2017 |
Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications. The European Journal of Neuroscience. 45: 1356. PMID 28523903 DOI: 10.1111/ejn.13573 |
0.641 |
|
| 2017 |
di Val Cervo PR, Romanov RA, Spigolon G, Masini D, Martín-Montañez E, Toledo EM, La Manno G, Feyder M, Pifl C, Ng YH, Sánchez SP, Linnarsson S, Wernig M, Harkany T, Fisone G, et al. Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model. Nature Biotechnology. PMID 28398344 DOI: 10.1038/Nbt.3835 |
0.458 |
|
| 2016 |
Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: Possible functional implications. The European Journal of Neuroscience. PMID 27741357 DOI: 10.1111/Ejn.13435 |
0.674 |
|
| 2016 |
Peneder TM, Bauer J, Pifl C. Apoptosis-inducing factor in nigral dopamine neurons: Higher levels in primates than in mice. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27297192 DOI: 10.1002/Mds.26695 |
0.458 |
|
| 2015 |
Pifl C, Reither H, Hornykiewicz O. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter. European Journal of Pharmacology. 755: 119-26. PMID 25771452 DOI: 10.1016/J.Ejphar.2015.03.004 |
0.652 |
|
| 2014 |
Pifl C, Rajput A, Reither H, Blesa J, Cavada C, Obeso JA, Rajput AH, Hornykiewicz O. Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 8210-8. PMID 24920625 DOI: 10.1523/Jneurosci.5456-13.2014 |
0.698 |
|
| 2013 |
Pifl C, Hornykiewicz O, Blesa J, Adánez R, Cavada C, Obeso JA. Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism. Journal of Neurochemistry. 125: 657-62. PMID 23331162 DOI: 10.1111/Jnc.12162 |
0.611 |
|
| 2012 |
Pifl C, Kish SJ, Hornykiewicz O. Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1618-24. PMID 23038412 DOI: 10.1002/Mds.25109 |
0.567 |
|
| 2012 |
Blesa J, Pifl C, Sánchez-González MA, Juri C, García-Cabezas MA, Adánez R, Iglesias E, Collantes M, Peñuelas I, Sánchez-Hernández JJ, Rodríguez-Oroz MC, Avendaño C, Hornykiewicz O, Cavada C, Obeso JA. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Neurobiology of Disease. 48: 79-91. PMID 22677034 DOI: 10.1016/J.Nbd.2012.05.018 |
0.665 |
|
| 2012 |
Sommerauer C, Rebernik P, Reither H, Nanoff C, Pifl C. The noradrenaline transporter as site of action for the anti-Parkinson drug amantadine. Neuropharmacology. 62: 1708-16. PMID 22155208 DOI: 10.1016/J.Neuropharm.2011.11.017 |
0.428 |
|
| 2011 |
Peneder TM, Scholze P, Berger ML, Reither H, Heinze G, Bertl J, Bauer J, Richfield EK, Hornykiewicz O, Pifl C. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice. Neuroscience. 180: 280-92. PMID 21333719 DOI: 10.1016/J.Neuroscience.2011.02.017 |
0.602 |
|
| 2010 |
Peneder TM, Berger M, Scholze P, Heinze G, Bertl J, Bauer J, Hornykiewicz O, Richfield EK, Pifl C. Interaction of manganese with striatal dopamine turnover in human alpha-synuclein transgenic mice Bmc Pharmacology. 10. DOI: 10.1186/1471-2210-10-S1-A16 |
0.578 |
|
| 2009 |
Pifl C, Wolf A, Rebernik P, Reither H, Berger ML. Zinc regulates the dopamine transporter in a membrane potential and chloride dependent manner. Neuropharmacology. 56: 531-40. PMID 19000913 DOI: 10.1016/J.Neuropharm.2008.10.009 |
0.447 |
|
| 2008 |
Rajput AH, Sitte HH, Rajput A, Fenton ME, Pifl C, Hornykiewicz O. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation. Neurology. 70: 1403-10. PMID 18172064 DOI: 10.1212/01.Wnl.0000285082.18969.3A |
0.653 |
|
| 2006 |
Pifl C, Sperk G. Current topics in brain dopamine research: a tribute to Professor Oleh Hornykiewicz. Wiener Klinische Wochenschrift. 118: 563-5. PMID 17136327 DOI: 10.1007/S00508-006-0719-6 |
0.434 |
|
| 2006 |
Pifl C, Hornykiewicz O. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys. Neurochemistry International. 49: 519-24. PMID 16698121 DOI: 10.1016/J.Neuint.2006.03.013 |
0.697 |
|
| 2005 |
Pifl C, Nagy G, Berényi S, Kattinger A, Reither H, Antus S. Pharmacological characterization of ecstasy synthesis byproducts with recombinant human monoamine transporters. The Journal of Pharmacology and Experimental Therapeutics. 314: 346-54. PMID 15831439 DOI: 10.1124/Jpet.105.084426 |
0.475 |
|
| 2005 |
Xu J, Zhong N, Wang H, Elias JE, Kim CY, Woldman I, Pifl C, Gygi SP, Geula C, Yankner BA. The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis. Human Molecular Genetics. 14: 1231-41. PMID 15790595 DOI: 10.1093/Hmg/Ddi134 |
0.363 |
|
| 2005 |
Woldman I, Reither H, Kattinger A, Hornykiewicz O, Pifl C. Dopamine inhibits cell growth and cell cycle by blocking ribonucleotide reductase. Neuropharmacology. 48: 525-37. PMID 15755480 DOI: 10.1016/J.Neuropharm.2004.11.013 |
0.663 |
|
| 2004 |
Rajput AH, Fenton ME, Di Paolo T, Sitte H, Pifl C, Hornykiewicz O. Human brain dopamine metabolism in levodopa-induced dyskinesia and wearing-off. Parkinsonism & Related Disorders. 10: 221-6. PMID 15120096 DOI: 10.1016/J.Parkreldis.2004.01.004 |
0.655 |
|
| 2004 |
Pifl C, Khorchide M, Kattinger A, Reither H, Hardy J, Hornykiewicz O. alpha-Synuclein selectively increases manganese-induced viability loss in SK-N-MC neuroblastoma cells expressing the human dopamine transporter. Neuroscience Letters. 354: 34-7. PMID 14698476 DOI: 10.1016/J.Neulet.2003.09.064 |
0.632 |
|
| 2004 |
Pifl C, Rebernik P, Kattinger A, Reither H. Zn2+ modulates currents generated by the dopamine transporter: parallel effects on amphetamine-induced charge transfer and release. Neuropharmacology. 46: 223-31. PMID 14680760 DOI: 10.1016/J.Neuropharm.2003.09.007 |
0.531 |
|
| 2002 |
Pifl C, Kattinger A, Reither H, Hornykiewicz O. Cellular effects of dopamine--beyond oxidative mechanisms. Parkinsonism & Related Disorders. 8: 433-7. PMID 12217632 DOI: 10.1016/S1353-8020(02)00028-7 |
0.65 |
|
| 2002 |
Kristufek D, Rudorfer W, Pifl C, Huck S. Organic cation transporter mRNA and function in the rat superior cervical ganglion. The Journal of Physiology. 543: 117-34. PMID 12181285 DOI: 10.1113/Jphysiol.2002.021170 |
0.366 |
|
| 2002 |
Pifl C, Caron MG. The Dopamine Transporter: Molecular Biology, Pharmacology and Genetics Handbook of Experimental Pharmacology. 154: 257-297. DOI: 10.1007/978-3-642-56051-4_10 |
0.406 |
|
| 2001 |
Pifl C, Zezula J, Spittler A, Kattinger A, Reither H, Caron MG, Hornykiewicz O. Antiproliferative action of dopamine and norepinephrine in neuroblastoma cells expressing the human dopamine transporter. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 1607-9. PMID 11427501 DOI: 10.1096/Fj.00-0738Fje |
0.73 |
|
| 2001 |
Sitte HH, Hiptmair B, Zwach J, Pifl C, Singer EA, Scholze P. Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Molecular Pharmacology. 59: 1129-37. PMID 11306696 DOI: 10.1124/Mol.59.5.1129 |
0.357 |
|
| 2000 |
Sitte HH, Scholze P, Schloss P, Pifl C, Singer EA. Characterization of carrier-mediated efflux in human embryonic kidney 293 cells stably expressing the rat serotonin transporter: a superfusion study. Journal of Neurochemistry. 74: 1317-24. PMID 10693966 DOI: 10.1046/J.1471-4159.2000.741317.X |
0.344 |
|
| 2000 |
Pifl C, Sitte HH, Reither H, Singer EA. The mechanism of the releasing action of amphetamine. Uptake, superfusion, and electrophysiological studies on transporter-transfected cells Pure and Applied Chemistry. 72: 1045-1050. DOI: 10.1351/Pac200072061045 |
0.517 |
|
| 2000 |
Pifl C, Sitte HH, Reither H, Singer EA. The mechanism of the releasing action of amphetamine. Uptake, superfusion, and electrophysiological studies on transporter-transfected cells Pure and Applied Chemistry. 72: 1045-1050. DOI: 10.1351/pac200072061045 |
0.427 |
|
| 1999 |
Pifl C, Singer EA. Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Molecular Pharmacology. 56: 1047-54. PMID 10531412 DOI: 10.1124/Mol.56.5.1047 |
0.467 |
|
| 1999 |
Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology. 53: 1032-41. PMID 10496263 DOI: 10.1212/Wnl.53.5.1032 |
0.649 |
|
| 1999 |
Pifl C, Agneter E, Drobny H, Sitte HH, Singer EA. Amphetamine reverses or blocks the operation of the human noradrenaline transporter depending on its concentration: superfusion studies on transfected cells. Neuropharmacology. 38: 157-65. PMID 10193907 DOI: 10.1016/S0028-3908(98)00155-5 |
0.465 |
|
| 1998 |
Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C. Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. Journal of Neurochemistry. 71: 1289-97. PMID 9721755 DOI: 10.1046/J.1471-4159.1998.71031289.X |
0.539 |
|
| 1997 |
Rinner WA, Pifl C, Lassmann H, Hörtnagl H. Induction of apoptosis in vitro and in vivo by the cholinergic neurotoxin ethylcholine aziridinium. Neuroscience. 79: 535-42. PMID 9200736 DOI: 10.1016/S0306-4522(96)00687-2 |
0.303 |
|
| 1997 |
Pifl C, Agneter E, Drobny H, Reither H, Singer EA. Induction by low Na+ or Cl- of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters. British Journal of Pharmacology. 121: 205-12. PMID 9154329 DOI: 10.1038/Sj.Bjp.0701137 |
0.437 |
|
| 1996 |
Wilson JM, Levey AI, Rajput A, Ang L, Guttman M, Shannak K, Niznik HB, Hornykiewicz O, Pifl C, Kish SJ. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology. 47: 718-26. PMID 8797470 DOI: 10.1212/Wnl.47.3.718 |
0.68 |
|
| 1996 |
Pifl C, Hornykiewicz O, Giros B, Caron MG. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter. The Journal of Pharmacology and Experimental Therapeutics. 277: 1437-43. PMID 8667208 |
0.737 |
|
| 1996 |
Pifl C, Giros B, Caron MG. The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse. Advances in Neurology. 69: 235-8. PMID 8615133 |
0.608 |
|
| 1995 |
Pifl C, Drobny H, Reither H, Hornykiewicz O, Singer EA. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter. Molecular Pharmacology. 47: 368-73. PMID 7870046 |
0.632 |
|
| 1994 |
Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, Caron MG. Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. The Journal of Biological Chemistry. 269: 15985-8. PMID 8206893 |
0.542 |
|
| 1993 |
Pifl C, Giros B, Caron MG. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 13: 4246-53. PMID 8410185 DOI: 10.1523/Jneurosci.13-10-04246.1993 |
0.734 |
|
| 1992 |
Pifl C, Reither H, Hornykiewicz O. Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat. Brain Research. 572: 87-93. PMID 1535275 DOI: 10.1016/0006-8993(92)90455-I |
0.671 |
|
| 1992 |
Pifl C, Schingnitz G, Hornykiewicz O. Striatal and non-striatal neurotransmitter changes in MPTP-parkinsonism in rhesus monkey: the symptomatic versus the asymptomatic condition. Neurochemistry International. 20: 295S-297S. PMID 1365445 DOI: 10.1016/0197-0186(92)90255-P |
0.634 |
|
| 1992 |
Pifl C, Nanoff C, Schingnitz G, Schütz W, Hornykiewicz O. Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease. Journal of Neurochemistry. 58: 1997-2004. PMID 1349341 DOI: 10.1111/J.1471-4159.1992.Tb10939.X |
0.652 |
|
| 1991 |
Pifl C, Reither H, Hornykiewicz O. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum. European Journal of Pharmacology. 202: 273-6. PMID 1839386 DOI: 10.1016/0014-2999(91)90304-9 |
0.648 |
|
| 1991 |
Pifl C, Schingnitz G, Hornykiewicz O. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience. 44: 591-605. PMID 1754053 DOI: 10.1016/0306-4522(91)90080-8 |
0.67 |
|
| 1990 |
Pifl C, Bertel O, Schingnitz G, Hornykiewicz O. Extrastriatal dopamine in symptomatic and asymptomatic rhesus monkeys treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neurochemistry International. 17: 263-70. PMID 20504626 DOI: 10.1016/0197-0186(90)90148-M |
0.684 |
|
| 1990 |
Yurdaydin C, Hörtnagl H, Steindl P, Zimmermann C, Pifl C, Singer EA, Roth E, Ferenci P. Increased serotoninergic and noradrenergic activity in hepatic encephalopathy in rats with thioacetamide-induced acute liver failure. Hepatology (Baltimore, Md.). 12: 695-700. PMID 1698704 DOI: 10.1002/Hep.1840120413 |
0.367 |
|
| 1990 |
Pifl C, Jachimowicz A, Urban G, Kohl F, Goiser P, Theiner J, Nauer GE. A new type of thin-layer microelectrode for in vivo voltammetry: Electro-oxidation of dopamine, DOPAC and ascorbic acid Sensors and Actuators: B. Chemical. 1: 468-472. DOI: 10.1016/0925-4005(90)80251-T |
0.35 |
|
| 1989 |
Pichler L, Pifl C. Locomotor behaviour of selective dopamine agonists in mice: is endogenous dopamine the only catecholamine involved? The Journal of Pharmacy and Pharmacology. 41: 690-3. PMID 2575146 DOI: 10.1111/J.2042-7158.1989.Tb06342.X |
0.38 |
|
| 1988 |
Pifl C, Schingnitz G, Hornykiewicz O. The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's disease. Neuroscience Letters. 92: 228-33. PMID 3263594 DOI: 10.1016/0304-3940(88)90066-3 |
0.668 |
|
| 1988 |
Pifl C, Hornykiewicz O. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation. European Journal of Pharmacology. 146: 189-91. PMID 3258244 DOI: 10.1016/0014-2999(88)90504-3 |
0.599 |
|
| 1988 |
Pifl C, Pichler L, Kobinger W, Hornykiewicz O. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat. European Journal of Pharmacology. 153: 33-44. PMID 2463928 DOI: 10.1016/0014-2999(88)90585-7 |
0.617 |
|
| 1987 |
Pichler L, Pifl C, Hornykiewicz O, Kobinger W. The dopamine autoreceptor agonist B-HT 920 inhibits in vivo dopamine release into the cerebroventricular system of cats. European Journal of Pharmacology. 135: 239-42. PMID 2884121 DOI: 10.1016/0014-2999(87)90618-2 |
0.679 |
|
| 1986 |
Hinzen D, Hornykiewicz O, Kobinger W, Pichler L, Pifl C, Schingnitz G. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. European Journal of Pharmacology. 131: 75-86. PMID 3816949 DOI: 10.1016/0014-2999(86)90517-0 |
0.625 |
|
| Show low-probability matches. |